Laboratory healthcare gap of hepatitis b care in yogyakarta, indonesia

Introduction: Serological markers of hepatitis B virus (HBV) infection (HBsAg, anti-HBs, hepatitis B envelope antigen HBeAg, anti-HBe, and anti-hepatitis B core HBc IgM/IgG) was used as the basis for diagnosis and differences in the chronicity of hepatitis B infection. This study aims to explore the laboratory healthcare gap of the patient with hepatitis B infection in our setting and whether laboratory data completeness affects the results. Methods: This study used retrospective data taken from the Medical Records of hepatitis B patients at Dr. Sardijto Hospital in 2020. The subjects in this study were hepatitis B patients with positive HBsAg. The exclusion criteria were individuals who had co-infection with the hepatotropic virus or HIV. This study was funded by Deputi Bidang Penguatan Riset dan Pengembangan, Kementerian Riset dan Teknologi/Badan Inovasi Nasional. Results: A total of 232 patients were included in the study. All patients underwent HBsAg examination and tested positive, with 65.09% of subjects had HBV DNA examination. HBeAg examination result was only found in 18% of patients. Anti HBc examinations were only found in 2 patients. No subjects were examined for anti-HBs in this study. The proportion of subjects examined for the liver function was still low (< 50%), with the most widely checked parameters are AST and ALT while other parameters are very rare. Conclusions: The utilization of serological tests and hepatic function in hepatitis B patients in Yogyakarta, Indonesia is still low. Intervention and financial support are needed to improve the quality of life of patients with hepatitis B who were treated. © The Korean Association of Hepato-Biliary-Pancreatic Surgery.